Listen Top Shows Blog

E160 - Ongoing challenges of off-label prescribing

E160 - Ongoing challenges of off-label prescribing

Update: 2024-03-25

2

Share

Description

Jo Cheah chats with clinical pharmacologist Richard Day about off-label prescribing. Ric explains why off-label prescribing occurs, the barriers to getting new indications added to a drug’s approved label, and the potential risks of off-label prescribing without sufficient evidence. Read the full article by Richard Day in Australian Prescriber.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

E178 – Reflections on community antimicrobial prescribing in Australia

E178 – Reflections on community antimicrobial prescribing in Australia

2024-12-0918:17

E177 - Inhaler device selection for people with asthma or chronic obstructive pulmonary disease

E177 - Inhaler device selection for people with asthma or chronic obstructive pulmonary disease

2024-11-2518:21

E176 - Managing medicine shortages

E176 - Managing medicine shortages

2024-11-1118:22

E175 - Pharmacological management of polycystic ovary syndrome

E175 - Pharmacological management of polycystic ovary syndrome

2024-10-2816:16

E174 - Achieving safe medication management during transitions of care from hospital

E174 - Achieving safe medication management during transitions of care from hospital

2024-10-1421:35

E173 - Management of occupational exposure to blood and body fluids in primary care

E173 - Management of occupational exposure to blood and body fluids in primary care

2024-09-3019:28

E172 - Utility of common investigations for suspected inflammatory arthritis in adults

E172 - Utility of common investigations for suspected inflammatory arthritis in adults

2024-09-1619:31

E171 - Controversies in the management of community-acquired pneumonia in adults

E171 - Controversies in the management of community-acquired pneumonia in adults

2024-09-0219:07

E170 - Quality use of medicines: who owns it now?

E170 - Quality use of medicines: who owns it now?

2024-08-2616:47

E169 - Deprescribing antihypertensives in frail older adults

E169 - Deprescribing antihypertensives in frail older adults

2024-08-0520:43

E168 - New and emerging drug therapies for Alzheimer disease

E168 - New and emerging drug therapies for Alzheimer disease

2024-07-2219:22

E167 - Diagnosis and management of obstructive sleep apnoea in adults

E167 - Diagnosis and management of obstructive sleep apnoea in adults

2024-07-0819:45

E166 - Biologic therapies for severe asthma with persistent type 2 inflammation

E166 - Biologic therapies for severe asthma with persistent type 2 inflammation

2024-06-2415:58

E165 - Assessing, communicating and managing cardiovascular disease risk

E165 - Assessing, communicating and managing cardiovascular disease risk

2024-06-1015:50

E164 - Diagnosis and management of eosinophilic oesophagitis

E164 - Diagnosis and management of eosinophilic oesophagitis

2024-05-2717:22

E163 - Managing pre-existing diabetes prior to and during pregnancy

E163 - Managing pre-existing diabetes prior to and during pregnancy

2024-05-1319:07

E162 - Management of menopause symptoms

E162 - Management of menopause symptoms

2024-04-2915:03

E161 - Managing hypercholesterolaemia

E161 - Managing hypercholesterolaemia

2024-04-0821:54

E160 - Ongoing challenges of off-label prescribing

E160 - Ongoing challenges of off-label prescribing

2024-03-2517:37

E159 - Therapeutic Guidelines Dermatology

E159 - Therapeutic Guidelines Dermatology

2024-03-1115:04

00:00

00:00

x

E160 - Ongoing challenges of off-label prescribing

E160 - Ongoing challenges of off-label prescribing